AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(5), 2001, pp. 523-527
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Seidlein, L
Right arrow Articles by Targett, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Seidlein, L
Right arrow Articles by Targett, G
Related Collections
Right arrow Epidemiology
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 5, 523-527
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Risk factors for gametocyte carriage in Gambian children

L von Seidlein, C Drakeley, B Greenwood, G Walraven, and G Targett

A widespread reduction in Plasmodium falciparum gametocyte prevalence could reduce malaria transmission. After infection with P. falciparum, a variable proportion of people are found to be gametocytemic. We analyzed risk factors associated with gametocytemia at presentation and 7 days later. We enrolled 1,198 children in 2 antimalarial drug trials between September and December 1998. The children were assigned to 1 of 4 treatment groups: chloroquine only; pyrimethamine-sulfadoxine (PSD) only; PSD combined with 1 dose of artesunate; and PSD combined with 3 doses of artesunate. By the time of enrollment, 200 (17%) of 1,198 children were gametocyte carriers. Three independent risk factors were associated with gametocytemia at enrollment. Children with anemia were more likely to carry gametocytes, whereas children with fever (> 37.4 degrees C) or high parasite densities (> 100,000 parasites/microL) were less frequently gametocyte carriers. Children with at least 2 of the risk factors were 4 times more likely to be gametocytemic than children with < 2 risk factors (odds ratio [OR], 4.4; 95% confidence interval [CI], 2.7-7.1). Seven days after the start of treatment, 355 (37%) of 466 assessable children were found to be gametocyte carriers. Children treated with PSD alone had a significantly higher risk of being gametocytemic by Day 7 compared with children in the other 3 treatment groups. In the subgroup of children who had no detectable gametocytes on enrollment, the effect of treatment with PSD + 3 doses of artesunate was most marked. Nineteen (10%) of 198 children treated with PSD + 3 doses of artesunate became gametocytemic, in contrast to 184 (57%) of 321 children treated with PSD alone (OR, 12.7; 95% CI, 7.3-22.1). Early treatment with highly effective antimalarial therapy has the greatest chance of preventing gametocytemia. The choice of a first-line antimalarial drug for uncomplicated malaria should not only take into consideration the ablation asexual parasitemia but also the suppression of gametocytemia.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
S. Thapa, J. Hollander, M. Linehan, J. Cox-Singh, M. B. Bista, G. D. Thakur, W. A. Davis, and T. M. E. Davis
Comparison of Artemether-Lumefantrine with Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria in Eastern Nepal
Am J Trop Med Hyg, September 1, 2007; 77(3): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. Sowunmi, G. O. Gbotosho, C. T. Happi, A. A. Adedeji, F. A. Fehintola, O. A. Folarin, E. Tambo, and B. A. Fateye
Therapeutic Efficacy and Effects of Artemether-Lumefantrine and Amodiaquine-Sulfalene-Pyrimethamine on Gametocyte Carriage in Children with Uncomplicated Plasmodium falciparum Malaria in Southwestern Nigeria
Am J Trop Med Hyg, August 1, 2007; 77(2): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Sowunmi, T. Balogun, G. O. Gbotosho, C. T. Happi, A. A. Adedeji, and F. A. Fehintola
Activities of Amodiaquine, Artesunate, and Artesunate-Amodiaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria in Children
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1694 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. NACHER, U. SILACHAMROON, P. SINGHASIVANON, P. WILAIRATANA, W. PHUMRATANAPRAPIN, A. FONTANET, and S. LOOAREESUWAN
RISK FACTORS FOR PLASMODIUM VIVAX GAMETOCYTE CARRIAGE IN THAILAND
Am J Trop Med Hyg, December 1, 2004; 71(6): 693 - 695.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
I. SUTANTO, S. SUPRIYANTO, P. RUCKERT, PURNOMO, J. D. MAGUIRE, and M. J. BANGS
COMPARATIVE EFFICACY OF CHLOROQUINE AND SULFADOXINE-PYRIMETHAMINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA AND IMPACT ON GAMETOCYTE CARRIAGE RATES IN THE EAST NUSATENGGARA PROVINCE OF INDONESIA
Am J Trop Med Hyg, May 1, 2004; 70(5): 467 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. J. Terlouw, B. L. Nahlen, J. M. Courval, S. K. Kariuki, O. S. Rosenberg, A. J. Oloo, M. S. Kolczak, W. A. Hawley, A. A. Lal, and F. O. t. Kuile
Sulfadoxine-Pyrimethamine in Treatment of Malaria in Western Kenya: Increasing Resistance and Underdosing
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2929 - 2932.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.